🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and cisplatin, w...
Status
Terminated
Location
Multiple Locations
Start Date
1999-08
Trial ID
NCT00530634
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2006-04
Trial ID
NCT00379509
This study will help us understand the gene expression profiles of lung can...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2002-02
Trial ID
NCT00568906
This phase I/II trial is studying the side effects and best dose of vorinos...
Status
Completed
Location
Puget Sound Oncology Consortium
Start Date
2007-12
Trial ID
NCT00601718
RATIONALE: Studying the genes expressed in samples of tumor tissue from pat...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00990873
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Completed
Location
Multiple Locations
Start Date
2005-10-07
Trial ID
NCT00897299
RATIONALE: Studying samples of tissue from patients with cancer in the labo...
Status
Completed
Location
Multiple Locations
Start Date
2011-12-22
Trial ID
NCT01487733
RATIONALE: Gathering information about genetic changes in patients with lob...
Status
Unknown
Location
Basildon University Hospital
Start Date
2007-06
Trial ID
NCT00536718
RATIONALE: Gold sodium thiomalate may stop the growth of tumor cells by blo...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2007-01-25
Trial ID
NCT00575393
Scoring systems that combine donor clinical and morphological parameters to...
Status
Completed
Location
Institute for Clinical and Experimental Medicine
Start Date
2021-06-11
Trial ID
NCT06171438